Completed NA INTERVENTIONAL NCT00012168

Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat

Lymphoscintigraphy Assisted Molecular Staging of Head and Neck Cancer

Sponsor: NYU Langone Health

Interventions immunohistochemistry staining method isosulfan blue lymphangiography polymerase chain reaction radionuclide imaging sentinel lymph node biopsy technetium Tc 99m sulfur colloid

Updated 7 times since 2017 Last updated: Mar 10, 2016 Started: May 31, 1999 Primary completion: Jul 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Head and Neck Cancer and is currently completed. NYU Langone Health leads this study, which shows 7 recorded versions since 1999 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Jun 2019 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

May 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NYU Langone Health
National Cancer Institute (NCI)

Data source: NYU Langone Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States